trial · primary record
Cebranopadol 400 ug
Pain
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 160 |
| Primary completion | 2027-02 |
| Primary endpoint | Sum of pain intensity differences through 48 hours (SPID48) |
| Registry ID | NCT07845071 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:46.557Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07845071
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.